CMF5 State-of-the-Art: Use of Hormones in Transgender Individuals

Program: Case Management Forums
Clinical Session
Saturday, April 2, 2016: 3:30 PM-4:15 PM
Room 205 (BCEC)
Joshua David Safer, MD, FACP, Boston University School of Medicine, Boston, MA and Benjamin Boh, DO, MS, Dartmouth-Hitchcock Medical Center, Lebanon, NH

JDS: Clinician, Boston University Medical Center, Employee, Parexel. Nothing to Disclose: BB
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire